The discovery of endothelium-dependent contraction: The legacy of Paul M. Vanhoutte

被引:22
作者
Barton, Matthias [1 ]
机构
[1] Univ Zurich, CH-8057 Zurich, Switzerland
基金
瑞士国家科学基金会;
关键词
Endothelium; Prostanoids; Vasoconstriction; Blood pressure; Endothelin; Nitric oxide; Vasoactive factors; VASCULAR SMOOTH-MUSCLE; NITRIC-OXIDE SYNTHASE; CANINE FEMORAL-ARTERY; RELAXING FACTOR; RECEPTOR ANTAGONISTS; CORONARY-ARTERIES; SUPEROXIDE ANION; VASOCONSTRICTOR SUBSTANCE; GENE-EXPRESSION; BLOOD-PRESSURE;
D O I
10.1016/j.phrs.2011.02.013
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This article summarizes the discovery and the development of endothelial biology with a special focus on the role of endothelium-dependent vasoconstriction. The physician-scientist Paul Michel Vanhoutte contributed many of the initial observations that helped to understand and form the main concepts of modern vascular biology involving endothelial regulation. His laboratory was the first to report endothelial cell-derived vasoconstriction in 1981, followed by the characterization of an endothelium-derived constricting factor published by Hickey et al. in 1985, which was later identified as the endothelin peptide by Yanagisawa et al. in 1988. The identification of the receptor subtypes of this endothelial vasocontrictor two years later, which were named ETA and ETB receptors according to suggestions put forward by Vanhoutte, ultimately resulted in the development of the only new class of drugs that is entirely based on endothelial cell research. More than a quarter century after Vanhoutte's initial description of endothelial vasoconstriction, this first drug class specifically targeting an endothelial vasoconstrictor, the endothelin receptor antagonists, has been firmly established in cardiovascular medicine for the treatment of pulmonary hypertension. This novel therapeutic principle had its beginnings in Vanhoutte's discovery made 30 years ago. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:455 / 462
页数:8
相关论文
共 112 条
  • [41] SUPEROXIDE ANION IS INVOLVED IN THE BREAKDOWN OF ENDOTHELIUM-DERIVED VASCULAR RELAXING FACTOR
    GRYGLEWSKI, RJ
    PALMER, RMJ
    MONCADA, S
    [J]. NATURE, 1986, 320 (6061) : 454 - 456
  • [42] Endothelial Function in the Time of the Giants
    Heistad, Donald D.
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2008, 52 (05) : 385 - 392
  • [43] CHARACTERIZATION OF A CORONARY VASOCONSTRICTOR PRODUCED BY CULTURED ENDOTHELIAL-CELLS
    HICKEY, KA
    RUBANYI, G
    PAUL, RJ
    HIGHSMITH, RF
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1985, 248 (05): : C550 - C556
  • [44] HYPOXIA INCREASES ENDOTHELIN RELEASE IN BOVINE ENDOTHELIAL-CELLS IN CULTURE, BUT EPINEPHRINE, NOREPINEPHRINE, SEROTONIN, HISTAMINE AND ANGIOTENSIN-II DO NOT
    HIEDA, HS
    GOMEZSANCHEZ, CE
    [J]. LIFE SCIENCES, 1990, 47 (03) : 247 - 251
  • [45] ENDOTHELIN RECEPTOR SUBTYPE-B MEDIATES SYNTHESIS OF NITRIC-OXIDE BY CULTURED BOVINE ENDOTHELIAL-CELLS
    HIRATA, Y
    EMORI, T
    EGUCHI, S
    KANNO, K
    IMAI, T
    OHTA, K
    MARUMO, F
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (04) : 1367 - 1373
  • [46] ENDOTHELIUM-DERIVED RELAXING FACTOR PRODUCED AND RELEASED FROM ARTERY AND VEIN IS NITRIC-OXIDE
    IGNARRO, LJ
    BUGA, GM
    WOOD, KS
    BYRNS, RE
    CHAUDHURI, G
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (24) : 9265 - 9269
  • [47] JELLIFFE RW, 1962, J PHARMACOL EXP THER, V135, P349
  • [48] The effect of the endothelin ETA receptor antagonist CI-1020 on hypoxic pulmonary vasoconstriction
    Jones, RD
    Wanstall, JC
    Gambino, A
    Morice, AH
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 374 (03) : 367 - 375
  • [49] Oxidative stress increases synthesis of big endothelin-1 by activation of the endothelin-1 promoter
    Kähler, J
    Mendel, S
    Weckmüller, J
    Orzechowski, HD
    Mittmann, C
    Köster, R
    Paul, M
    Meinertz, T
    Münzel, T
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2000, 32 (08) : 1429 - 1437
  • [50] Oxidative stress increases endothelin-1 synthesis in human coronary artery smooth muscle cells
    Kähler, J
    Ewert, A
    Weckmüller, J
    Stobbe, S
    Mittmann, C
    Köster, R
    Paul, M
    Meinertz, T
    Münzel, T
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2001, 38 (01) : 49 - 57